| Elixir Energy Limited (EXR) ORDINARY FULLY PAID |
Energy |
$39 |
Noosa Conference Presentation
|
14 Nov 2024 8:38AM |
$0.052 |
$0.028 |
fallen by
46.15%
|
|
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$21 |
2024 AGM Presentation
|
14 Nov 2024 8:36AM |
$0.033 |
$0.028 |
fallen by
15.15%
|
|
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$345 |
Update - Notification of buy-back - AMH
|
14 Nov 2024 8:36AM |
$1.165 |
$1.095 |
fallen by
6.01%
|
|
| Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,586 |
Dividend/Distribution - GNC
|
14 Nov 2024 8:36AM |
$8.850 |
$7.150 |
fallen by
19.21%
|
|
| Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,586 |
FY24 Corporate Governance Statement and Appendix 4G
|
14 Nov 2024 8:35AM |
$8.850 |
$7.150 |
fallen by
19.21%
|
|
| Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,586 |
FY24 Sustainability Report
|
14 Nov 2024 8:35AM |
$8.850 |
$7.150 |
fallen by
19.21%
|
|
| Immutep Limited (IMM) ORDINARY FULLY PAID |
Health Care |
$409 |
Positive Data from Phase II Trial in Soft Tissue Sarcoma
|
14 Nov 2024 8:34AM |
$0.310 |
$0.280 |
fallen by
9.68%
|
|
IMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Efti combined with pembrolizumab and radiotherapy shows significant efficacy in soft tissue sarcoma.
- Over three-fold increase in tumor hyalinization, an important predictor of survival.
- The study involved 21 patients, with a primary analysis demonstrating strong efficacy.
- 71.4% of patients achieved a pathologic response with the combination therapy.
- No grade =3 toxicities related to efti and pembrolizumab were reported.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Seven Group Holdings Limited (SVW) ORDINARY FULLY PAID |
Industrials |
$18,632 |
Annual General Meeting Addresses and Presentation
|
14 Nov 2024 8:34AM |
$44.330 |
$45.780 |
risen by
3.27%
|
|
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$21 |
AGM Chair Address
|
14 Nov 2024 8:33AM |
$0.033 |
$0.028 |
fallen by
15.15%
|
|
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$113 |
Update - Notification of buy-back - CAM
|
14 Nov 2024 8:31AM |
$0.780 |
$0.750 |
fallen by
3.85%
|
|
| Stockland (SGP) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$13,271 |
Stockland announces Distribution Reinvestment Plan
|
14 Nov 2024 8:31AM |
$5.160 |
$5.530 |
risen by
7.17%
|
|
| Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,586 |
FY24 Investor Presentation
|
14 Nov 2024 8:30AM |
$8.850 |
$7.150 |
fallen by
19.21%
|
|
GNC - Price-sensitive ASX Announcement
Full Release
Key Points
- Underlying EBITDA of $268 million for FY24.
- Total grain handled of 28.0 million tonnes.
- Record oilseed crush volumes of 540,000 tonnes.
- Acquisition of XF Australia completed in April 2024.
- Ongoing improvements in Agri-energy and Animal Nutrition sales volumes.
- Strong balance sheet with core cash of $337 million.
- Earnings guidance to be provided at AGM in February 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,586 |
FY24 Results Announcement
|
14 Nov 2024 8:30AM |
$8.850 |
$7.150 |
fallen by
19.21%
|
|
GNC - Price-sensitive ASX Announcement
Full Release
Key Points
- Underlying EBITDA: $268 million, down from $565 million in FY23
- Net Profit After Tax: $62 million, down from $250 million in FY23
- Core cash balance at $337 million, providing flexibility for growth
- Record year in oilseed crush volumes
- Acquisition of XF Australia expanded Animal Nutrition portfolio
- Dividends declared at 48 cents per share, down from 54 cents in FY23
- Challenges from lower grain production and increased global supply affected margins
- Sustainability achievements discussed in FY24 Sustainability Report
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Xero Limited (XRO) ORDINARY FULLY PAID |
Information Technology |
$26,708 |
FY25 Interim Results Investor Presentation
|
14 Nov 2024 8:30AM |
$161.550 |
$173.860 |
risen by
7.62%
|
|
XRO - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 25% year-on-year to NZD 996 million.
- Strong subscriber growth with 4.19 million subscribers, up 13% year-on-year.
- Operating revenue grew by 25% year-on-year.
- Continued adherence to the Rule of 40, with robust free cash flow margins.
- Removal of long idle subscriptions enhances overall business focus.
- Strategic investments in accounting, payroll, and payments to drive future growth.
- Ambition to double the size of the business over the coming years.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Galileo Mining Ltd (GAL) ORDINARY FULLY PAID |
Materials |
$22 |
Galileo Mining Investor Presentation
|
14 Nov 2024 8:29AM |
$0.135 |
$0.110 |
fallen by
18.52%
|
|
| Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,586 |
FY24 Appendix 4E and Annual Report
|
14 Nov 2024 8:28AM |
$8.850 |
$7.150 |
fallen by
19.21%
|
|
GNC - Price-sensitive ASX Announcement
Full Release
Key Points
- Underlying EBITDA for FY24 was $268 million, down from $565 million in FY23.
- The Underlying NPAT decreased to $77 million in FY24, compared to $250 million in FY23.
- ECA business handled 28 million tonnes of grain, down from 37.4 million tonnes in FY23.
- GrainCorp declared a final dividend of 24 cents per share, totaling 48 cents in dividends for FY24.
- The company focused on sustainability goals and achieved improvements in key environmental metrics.
- GrainCorp launched the GrainCorp Next initiative to optimize GHG emission reduction across supply chains.
- Safety remained a core value with a significant increase in hazard reporting and a focus on achieving zero harm.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Qantas Airways Limited (QAN) ORDINARY FULLY PAID |
Industrials |
$15,117 |
Update - Notification of buy-back - QAN
|
14 Nov 2024 8:28AM |
$8.600 |
$9.990 |
risen by
16.16%
|
|
| Xero Limited (XRO) ORDINARY FULLY PAID |
Information Technology |
$26,708 |
FY25 Interim Results Market Release
|
14 Nov 2024 8:28AM |
$161.550 |
$173.860 |
risen by
7.62%
|
|
XRO - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating revenue increased to $995.9 million, supported by a balance of ARPU expansion and subscriber growth.
- Subscribers reached 4.186 million, with a free cash flow of $208.7 million.
- Total lifetime value of subscribers increased by 15% to $17.0 billion.
- Product highlights included the launch of Tap to Pay and improvements in bank feeds.
- Xero announced plans to acquire Sy Analytics to enhance reporting and analytics capabilities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Catapult Group International Limited (CAT) ORDINARY FULLY PAID |
Information Technology |
$1,162 |
1H FY25 Results Presentation
|
14 Nov 2024 8:28AM |
$2.630 |
$4.280 |
risen by
62.74%
|
|
CAT - Price-sensitive ASX Announcement
Full Release
Key Points
- ACV increased to US$96.8 million, up 20% year-over-year.
- Revenue reached US$57.8 million, reflecting a 19% increase year-over-year.
- ACV retention rate remained high at 96.2%.
- Pro Team metrics showed significant growth.
- Future revenue growth is expected due to strong SaaS performance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Catapult Group International Limited (CAT) ORDINARY FULLY PAID |
Information Technology |
$1,162 |
1H FY25 Results Release
|
14 Nov 2024 8:28AM |
$2.630 |
$4.280 |
risen by
62.74%
|
|
CAT - Price-sensitive ASX Announcement
Full Release
Key Points
- ACV grew 20% YoY reaching US$96.8M.
- Revenue increased to US$57.8M, up 19% YoY.
- Free Cash Flow of US$4.8M was generated in 1H FY25.
- Performance & Health vertical saw 22% ACV growth.
- Tactics & Coaching vertical's ACV grew 18%, with New Video Solutions increasing 42%.
- ACV Retention rate was strong at 96.2%.
- Customer Lifetime Duration increased to 7.6 years.
- Pro Team Customers increased by 7.9% YoY to 3,470 teams.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Catapult Group International Limited (CAT) ORDINARY FULLY PAID |
Information Technology |
$1,162 |
Appendix 4D and Half Year Statutory Accounts
|
14 Nov 2024 8:28AM |
$2.630 |
$4.280 |
risen by
62.74%
|
|
CAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Catapult is a global leader in wearable tracking technology for sports performance.
- The company reported a 16.2% increase in revenues for the half-year period.
- Loss after tax improved from US$8,386k to US$7,447k year-on-year.
- Annualized Contract Value increased by 21.5% to US$96,821k.
- Catapult offers technology solutions across multiple verticals in sports analytics.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vita Life Sciences Limited (VLS) ORDINARY FULLY PAID |
Health Care |
$102 |
Daily share buy-back notice - Appendix 3E
|
14 Nov 2024 8:27AM |
$2.090 |
$1.850 |
fallen by
11.48%
|
|
| Universal Store Holdings Limited (UNI) ORDINARY FULLY PAID |
Consumer Discretionary |
$636 |
Change of Director's Interest Notice - A Barbery
|
14 Nov 2024 8:27AM |
$7.780 |
$8.290 |
risen by
6.56%
|
|
| Alcidion Group Limited (ALC) ORDINARY FULLY PAID |
Health Care |
$114 |
Alcidion secures contract with NALHN
|
14 Nov 2024 8:27AM |
$0.054 |
$0.085 |
risen by
57.41%
|
|
ALC - Price-sensitive ASX Announcement
Full Release
Key Points
- Alcidion secures contract with NALHN for patient flow management.
- Contract value is $4.5 million over five years.
- Miya Precision will support real-time patient flow management.
- Initial two-year commitment with rights to extend to five years.
- Contract awarded after a competitive tender process.
- First deployment of Miya Precision in South Australia.
- Focus on improving patient access and operational efficiencies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Viva Leisure Limited (VVA) ORDINARY FULLY PAID |
Consumer Discretionary |
$132 |
Update - Notification of buy-back - VVA
|
14 Nov 2024 8:27AM |
$1.470 |
$1.300 |
fallen by
11.56%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
